Faysal JM - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

AHRQ's comparative effectiveness research on oral medications for type 2 diabetes: a summary of the key findings.

Bennett WL, Balfe LM, Faysal JM. Bennett WL, et al. Among authors: faysal jm. J Manag Care Pharm. 2012 Jan-Feb;18(1 Suppl A):1-22. doi: 10.18553/jmcp.2012.18.S1-A.1. J Manag Care Pharm. 2012. PMID: 22313233 Review.

Review of regulatory programs and new opioid technologies in chronic pain management: balancing the risk of medication abuse with medical need.

Fishbain D, Johnson S, Webster L, Greene L, Faysal J. Fishbain D, et al. J Manag Care Pharm. 2010 May;16(4):276-87. doi: 10.18553/jmcp.2010.16.4.276. J Manag Care Pharm. 2010. PMID: 20433218 Review. No abstract available.

Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer.

Lyons LS, Rao S, Balkan W, Faysal J, Maiorino CA, Burnstein KL. Lyons LS, et al. Mol Endocrinol. 2008 Mar;22(3):597-608. doi: 10.1210/me.2007-0158. Epub 2007 Dec 13. Mol Endocrinol. 2008. PMID: 18079321 Free PMC article.

Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21(CIP1) levels in androgen-independent human prostate cancer cells.

Knight-Krajewski S, Welsh CF, Liu Y, Lyons LS, Faysal JM, Yang ES, Burnstein KL. Knight-Krajewski S, et al. Among authors: faysal jm. Oncogene. 2004 Jul 15;23(32):5513-22. doi: 10.1038/sj.onc.1207708. Oncogene. 2004. PMID: 15077174

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results